Academic/Biomedical Research
News & Jobs

Employers
Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

News | News By Subject | News by Disease | News By Date | Search News

Get Our Industry eNewsletter FREE

email:

Taligen Therapeutics Receives Bioscience Company of the Year Award; CSO Holers Honored with Lifetime Achievement Award

6/23/2010 6:35:28 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has been selected as the Bioscience Company of the Year by the University of Colorado with its 7th Annual Technology Transfer Awards in recognition of its leadership position in developing a pipeline of novel protein therapeutics that modulate the complement system to treat a wide range of inflammatory diseases. In addition, V. Michael Holers, Ph.D., Taligen’s Co-Founder and Chief Scientific Officer and a Professor at the University of Colorado, Denver, was honored with the Pinnacle of Inventorship Lifetime Achievement Award for his unparalleled career as one of the world’s leading experts in complement biology.

Read at BioSpace.com

• BioSpace.com

• Taligen Therapeutics

• Biotech/Pharma - Background